Reasearch Awards nomination

Email updates

Keep up to date with the latest news and content from WJSO and BioMed Central.

Open Access Highly Accessed Research

Increase of cyclooxygenase-2 inhibition with celecoxib combined with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a subcutaneous implantation tumor model of human colon cancer

De-Qing Zhang1, Qiang Guo2, Jian-Hong Zhu1 and Wei-Chang Chen1*

Author Affiliations

1 Department of Digestion Internal Medicine, The First Affiliated Hospital of Soochow University, Su Zhou, JiangSu 215006, China

2 Department of Emergency and Intensive Care Unit, The First Affiliated Hospital of Soochow University, Su Zhou, JiangSu 215006, China

For all author emails, please log on.

World Journal of Surgical Oncology 2013, 11:16  doi:10.1186/1477-7819-11-16

Published: 24 January 2013

Abstract

Background

The purpose of this study was to investigate the anti-tumor effect and explore the mechanisms of celecoxib (a selective cyclooxygenase-2 inhibitor) combined with 5-fluorouracil (5-FU) on the treatment of human colorectal cancer in a BALB/C nude mouse subcutaneous xenograft model.

Methods

Effects of celecoxib combined with 5-FU on the proliferation of xenograft carcinoma induced by HT-29 were investigated. The apoptotic cells were detected by electron microscope and TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assay. Immunohistochemistry and Western blot were used to estimate the expression of cytochrome C, caspase-3 and caspase-9.

Results

Compared with the control group, treatment groups showed significant inhibition of tumor growth. More apoptotic cells existed after treatment with celecoxib combined with 5-FU. Cytochrome C, caspase-3 and caspase-9 were increased in treated groups, and more obviously in the drug combination group. Cyclooxygenase-2 (COX-2) were decreased after treatment with celecoxib only or combined with 5-FU. And the combined group showed a greater decrease.

Conclusions

Celecoxib combined with 5-FU could inhibit the growth of tumors in vivo by inducing apoptosis and activation of the cytochrome C dependency apoptosis signal pathway. A decrease of COX-2 and an increase of cytochrome C, caspase-3 and caspase-9 may be involved in this process.

Keywords:
Celecoxib; 5-Fluorouracil; Colorectal cancer; Apoptosis